Outset Medical, Inc.
OM
$4.56
$0.122.70%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.65% | 2.47% | -7.84% | -12.80% | -13.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.65% | 2.47% | -7.84% | -12.80% | -13.00% |
| Cost of Revenue | -5.77% | -9.50% | -21.92% | -26.68% | -25.21% |
| Gross Profit | 27.48% | 32.36% | 34.49% | 35.44% | 35.41% |
| SG&A Expenses | -24.44% | -28.18% | -25.62% | -21.90% | -17.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.11% | -26.28% | -28.36% | -26.56% | -21.70% |
| Operating Income | 47.00% | 49.37% | 44.64% | 37.30% | 28.37% |
| Income Before Tax | 37.87% | 38.55% | 32.63% | 26.00% | 19.89% |
| Income Tax Expenses | 1.98% | -22.31% | -9.94% | -6.12% | 27.79% |
| Earnings from Continuing Operations | 37.70% | 38.50% | 32.56% | 25.94% | 19.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 37.70% | 38.50% | 32.56% | 25.94% | 19.76% |
| EBIT | 47.00% | 49.37% | 44.64% | 37.30% | 28.37% |
| EBITDA | 48.54% | 51.01% | 46.15% | 38.59% | 29.41% |
| EPS Basic | 68.50% | 57.53% | 42.89% | 29.32% | 23.20% |
| Normalized Basic EPS | 73.94% | 61.91% | 46.50% | 33.10% | 25.77% |
| EPS Diluted | 68.50% | 57.53% | 42.89% | 29.32% | 23.20% |
| Normalized Diluted EPS | 73.94% | 61.91% | 46.50% | 33.10% | 25.77% |
| Average Basic Shares Outstanding | 236.71% | 134.91% | 31.21% | 4.99% | 4.72% |
| Average Diluted Shares Outstanding | 236.71% | 134.91% | 31.21% | 4.99% | 4.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |